Webcast ImageWebcast
Ocular Therapeutix, Inc. at the H.C. Wainwright Global Life Sciences Conference (Replay)
04/08/19 at 2:10 p.m. UKT
Ocular Therapeutix, Inc. at the H.C. Wainwright Global Life Sciences Conference
Monday, April 8, 2019 2:10 p.m. UKT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
2019 Research & Development Day (Replay)
03/28/19 at 7:30 a.m. ET
2019 Research & Development Day
Thursday, March 28, 2019 7:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to reduce the complexity and burden of current drop or injection regimens by creati
NASDAQ OCUL (Common Stock)
$3.81 + 0.15
Stock chart for: OCUL.O.  Currently trading at $3.81 with a 52 week high of $8.28 and a 52 week low of $3.46.
Data provided by Nasdaq. Minimum 15 minutes delayed.
Receive E-mail Alerts
You may sign up to receive Ocular Therapeutix, Inc. financial updates by email. Please enter your email address below and click SUBMIT.